Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
How biosimilar developers are embracing next phase of US market
Although the so-called biosimilar ‘void’ could pose challenges to upcoming biosimilar availability, the opportunity it presents is also immense.
Zoey Becker
,
Fraiser Kansteiner
Jul 6, 2026 10:03am
Allergan Aesthetics, Girls Inc. help map paths for women in STEM
Jul 8, 2026 8:47pm
Drugmaker caught faking doctors’ petition to evade China price cut
Jul 8, 2026 11:31am
Trial results set up Keenova to gain 3rd indication for Xiaflex
Jul 8, 2026 11:27am
Evonik charts $100M upgrade to Indiana drug substance plant
Jul 8, 2026 10:22am
Vera’s dual-target atacicept wins FDA approval for IgAN
Jul 7, 2026 12:23pm
More News
Novartis dismisses 322 more staffers based out of US headquarters
Jul 7, 2026 11:41am
BMS details Krazati confirmatory fail in colorectal cancer
Jul 7, 2026 10:46am
Regulatory tracker: AbbVie, Genmab's bispecific wins EU expansion
Jul 7, 2026 10:15am
Tanabe to sell manufacturing unit, rights to 17 meds to Towa
Jul 7, 2026 8:54am